You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Second Primary Cancers in Subsites of Colon and Rectum in Patients With Previous Colorectal Cancer

Liu, Lifang M.D., Ph.D.1; Lemmens, Valery E. P. P. Ph.D.1,2; De Hingh, Ignace H. J. T. M.D., Ph.D.3; de Vries, Esther Ph.D.1; Roukema, Jan Anne M.D., Ph.D.5,6; van Leerdam, Monique E. M.D., Ph.D.4; Coebergh, Jan Willem M.D., Ph.D.1,2; Soerjomataram, Isabelle M.D., Ph.D.1

Diseases of the Colon & Rectum:
doi: 10.1097/DCR.0b013e318279eb30
Original Contribution: Colorectal/Anal Neoplasia
Abstract

BACKGROUND: Compared with the general population, patients with a previous colorectal cancer are at higher risk for a second colorectal cancer, but detailed risk analysis by subsite is scarce.

OBJECTIVE: Our goal was to investigate the risk of a second cancer in relation to subsite as a basis for planning surveillance strategies,.

DESIGN, SETTING, AND PATIENTS: This was a retrospective analysis of a prospectively designed, population-based cancer registry (The Netherlands Cancer Registry). Patients with a stage I, II, or III colorectal cancer diagnosed between 1989 and 2008 were included.

MAIN OUTCOME MEASURES: Cumulative incidence, standardized incidence ratio, and absolute excess risk for second primary cancers in subsites of the colon and rectum were estimated for follow-up periods of 2 to 5, 6 to 10, and more than 10 years after the index cancer in patients older than 50 years and in those aged 50 years or younger.

RESULTS: A total of 123,347 patients had a first invasive colorectal cancer diagnosed between 1989 and 2008. Of these, 1849 patients (1.5%) had a second colorectal lesion that was found more than 1 year after the initial cancer and diagnosed as a second primary colorectal cancer. In patients older than 50 years, the 20-year cumulative incidence for second cancers was 3.4% in the proximal colon, 1.2% in the distal colon, and 1.2% in the rectum. More than 60% of second cancers occurred within 5 years after the index cancer. The standardized incidence ratio was highest in the proximal-colon (1.9; 95% CI, 1.8–2.0), followed by the distal-colon (1.0, 95% CI, 0.9–1.1), and the rectum (0.9, 95% CI, 0.8–1.0). The corresponding absolute excess risks per 10 000 person years were 9 in the proximal colon, 0.1 in the distal colon, and 1 in the rectum. After 5 years of follow-up, elevated risk was observed only in the proximal colon. A similar risk pattern was observed in patients younger than 50 years. The absolute excess risk for a second cancer in the proximal colon increased over time. The proportion of stage III and stage IV second cancers increased from 31% during the first 5 years of follow-up to 38% after 10 years of follow-up.

LIMITATIONS: Limitations of this study included lack of data regarding polypectomy rates and interval of surveillance colonoscopies.

CONCLUSIONS: Compared with the general population, individuals with previous colorectal cancer have a higher risk for a second cancer in all subsites of the colon and rectum. Among long-term survivors older than 50 years, risk remains elevated only in the proximal colon. Further studies should be encouraged to develop a suitable surveillance method for aging, high-risk, long-term colorectal cancer survivors.

Author Information

1 Department of Public Health, ErasmusMC, University Medical Center, Rotterdam, The Netherlands

2 Comprehensive Cancer Centre South (IKZ), Eindhoven, The Netherlands

3 Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands

4 Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, The Netherlands

5 Department of Surgery, St. Elisabeth Hospital, Tilburg, The Netherlands

6 Tilburg School of Social and Behavioral Sciences, University of Tilburg, Tilburg, The Netherlands

Funding/Support: This work was supported by Dutch Cancer Society (KWF): The increasing burden of second primary cancers in the Netherlands: trend in incidence, survival and causes-of-death since 1970 (EMCR 2008–4132).

Financial Disclosure: None reported.

Correspondence: Valery Lemmens, Ph.D., ErasmusMC University Medical Center, Department of Public Health, Room AE-233, Postbox 2040, 3000 CA Rotterdam, The Netherlands. E-mail: v.lemmens@erasmusmc.nl

© The ASCRS 2013